Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAVENDER, Matthew A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trialsCAVENDER, Matthew A; SABATINE, Marc S.Lancet (British edition). 2014, Vol 384, Num 9943, pp 599-606, issn 0140-6736, 8 p.Article

Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) TrialNICHOLLS, Stephen J; CAVENDER, Matthew A; KASTELEIN, John J. P et al.Cardiovascular drugs and therapy. 2012, Vol 26, Num 1, pp 71-75, issn 0920-3206, 5 p.Article

Safety of Bridging With Eptifibatide for Patients With Coronary Stents Before Cardiac and Non-Cardiac SurgeryRASSI, Andrew N; BLACKSTONE, Eugene; MILITELLO, Michael A et al.The American journal of cardiology. 2012, Vol 110, Num 4, pp 485-490, issn 0002-9149, 6 p.Article

Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)CAVENDER, Matthew A; MILFORD-BELAND, Sarah; ROE, Matthew T et al.The American journal of cardiology. 2009, Vol 104, Num 4, pp 507-513, issn 0002-9149, 7 p.Article

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized TrialSCIRICA, Benjamin M; BRAUNWALD, Eugene; POLLACK, Pia S et al.Circulation (New York, N.Y.). 2014, Vol 130, Num 18, pp 1579-1588, issn 0009-7322, 10 p.Article

Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome: The VISTA-16 Randomized Clinical TrialNICHOLLS, Stephen J; KASTELEIN, John J. P; WRIGHT, R. Scott et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 3, pp 252-262, issn 0098-7484, 11 p.Article

Temporal Trends and Predictors in the Use of Aldosterone Antagonists Post-Acute Myocardial InfarctionRASSI, Andrew N; CAVENDER, Matthew A; SCHWAMM, Lee H et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 1, pp 35-40, issn 0735-1097, 6 p.Article

Patient and Hospital Characteristics Associated With Inappropriate Percutaneous Coronary InterventionsCHAN, Paul S; RAO, Sunil V; BHATT, Deepak L et al.Journal of the American College of Cardiology. 2013, Vol 62, Num 24, pp 2274-2281, issn 0735-1097, 8 p.Article

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusSCIRICA, Benjamin M; BHATT, Deepak L; CAVENDER, Matthew A et al.The New England journal of medicine. 2013, Vol 369, Num 14, pp 1317-1326, issn 0028-4793, 10 p.Article

Alterations in the fibrinolytic cascade post-transplant : Evidence of a bimodal expression patternBENZA, Raymond L; CAVENDER, Matthew A; BARCHUE, Joseph et al.The Journal of heart and lung transplantation. 2007, Vol 26, Num 5, pp 494-497, issn 1053-2498, 4 p.Article

Donor PAI-1 expression inhibits the intimal response of early allograft vascular diseaseBENZA, Raymond L; ANDERSON, Peter G; LYLE, Kerry et al.The Journal of heart and lung transplantation. 2003, Vol 22, Num 5, pp 515-518, issn 1053-2498, 4 p.Article

  • Page / 1